Ipriflavone and osteoporosis.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Journal of the American Medical Association (JAMA)

• Publication date

  2001-10-17

• Fields of study

  Medicine

• Identifiers
  DOI 10.1001/JAMA.286.15.1836PMID 11597279
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Ipriflavone in the treatment of postmenopausal osteoporosis: a randomized controlled trial.

  2001cited by this paper
• Trabecular bone density in a two year controlled trial of peroral magnesium in osteoporosis.

  1993cited by this paper

• Construction of microgravity biological knowledge graph and its applications in anti-osteoporosis drug prediction.

  2024cites this paper
• The Efficacy and Safety of Ipriflavone in Postmenopausal Women with Osteopenia or Osteoporosis: A Systematic Review and Meta-analysis.

  2020cites this paper
• Propofol attenuates osteoclastogenesis by lowering RANKL/OPG ratio in mouse osteoblasts

  2018cites this paper
• Effects of propofol-induced autophagy against oxidative stress in human osteoblasts

  2016cites this paper
• Tridax procumbens flavonoids promote osteoblast differentiation and bone formation

  2015cites this paper
• Radix Dipsaci total saponins stimulate MC3T3-E1 cell differentiation via the bone morphogenetic protein-2/MAPK/Smad-dependent Runx2 pathway.

  2015cites this paper
• Asperosaponin VI, A Saponin Component from Dipsacus asper Wall, induces Osteoblast Differentiation through Bone Morphogenetic Protein‐2/p38 and Extracellular Signal‐regulated Kinase 1/2 Pathway

  2011cites this paper
• Syringetin, a flavonoid derivative in grape and wine, induces human osteoblast differentiation through bone morphogenetic protein-2/extracellular signal-regulated kinase 1/2 pathway.

  2009cites this paper
• Myricetin induces human osteoblast differentiation through bone morphogenetic protein-2/p38 mitogen-activated protein kinase pathway.

  2007cites this paper
• Piceatannol stimulates osteoblast differentiation that may be mediated by increased bone morphogenetic protein-2 production.

  2006cites this paper